[ May 10 (Thu) ]
Global Regulatory & Commercial Outlook in Cell & Gene Therapy / Opportunities in Global Regenerative Medicine Markets


Recent updates and case studies in global regulatory landscape in Regenerative Medicine industry specifically with respect to Cell & Gene therapy.


Session Chair Antonio Lee, Global Head, Business Development, MEDIPOST
Time Session Title
09 : 30 ~ 09 : 50 Cell & Gene Therapy Outlook in Korea
Antonio Lee, Global Head, Business Development, MEDIPOST
09 : 50 ~ 10 : 20 Matching The Latest Scientific Innovations in Cell and Gene Therapeutics to Regulatory Obligations
Tim Farries, Director, Regulatory-Gene and Cell Therapies, ERA Consulting
10 : 20 ~ 10 : 50 Regenerative Medicine in Japan
Colin Novick, Managing Director, CJ Partners
10 : 50 ~ 11 : 20 Regulatory Consideration of Cell Therapy Development in China – CRO Interpretation of CFDA Requirements
Mingping Zhang, VP, PAREXEL Consulting
Panel Discussion
11 : 20 ~ 11 : 50 Q&A
Antonio Lee, Global Head, Business Development , MEDIPOST
Tim Farries, Director, Regulatory-Gene and Cell Therapies, ERA Consulting
Colin Novick, Managing Director, CJ Partners
Mingping Zhang, VP, PAREXEL Consulting